Krystal Biotech buy Citigroup Inc.
Start price
12.01.26
/
50%
€233.70
Target price
12.01.27
€288.19
Performance (%)
-2.52%
Price
07:36
€227.80
Summary
This prediction is currently active. With a performance of -2.52%, the BUY prediction for Krystal Biotech by Citigroup_Inc_ is down slightly. This prediction currently runs until 12.01.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Krystal Biotech | 5.907% | 5.907% |
| iShares Core DAX® | 4,85 % | -2,75 % |
| iShares Nasdaq 100 | 4,00 % | -3,33 % |
| iShares Nikkei 225® | 4,22 % | -2,91 % |
| iShares S&P 500 | 3,32 % | -2,95 % |
Comments by Citigroup_Inc_ for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech (NASDAQ:KRYS) had its price target raised by analysts at Citigroup Inc. from $320.00 to $336.00. They now have a "buy" rating on the stock.
Ratings data for KRYS provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€152.00
27.02.24
27.02.24
€179.60
27.02.25
27.02.25
14.14%
28.02.25
28.02.25
